Company / Operating Income
LEXICON PHARMACEUTICALS, INC. Operating Income History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$171.8M
FY2025
5-year range
-$171.8M / -$47.8M
FY2021-FY2025
Trend
-70.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has declined for 3 consecutive years, from -$48M in FY2019 to -$172M in FY2025.
Based on SEC 10-K filings.
-$172M in FY2025.
Declined from -$87M to -$172M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- LEXICON PHARMACEUTICALS, INC.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 70.5% year-over-year.
- Peak operating income was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$171.8M | -70.5% |
| FY2024 | -$100.8M | -15.7% |
| FY2023 | -$87.1M | -82.2% |
| FY2019 | -$47.8M | +62.4% |
| FY2018 | -$127.2M | -8762.9% |
| FY2017 | $1.5M | +101.5% |
| FY2016 | -$100.4M | +2.0% |
| FY2015 | -$102.4M | +5.6% |
| FY2014 | -$108.4M | +5.0% |
| FY2013 | -$114.1M | -19.2% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026